October 08, 2009

Hosted at the New York Academy of Medicine

New York City, NY - September 26, 2009 - The Cancer Institute at NYU Langone Medical Center held its 6th annual retreat at the New York Academy of Medicine on September 25. Each year the retreat provides an opportunity for Cancer Institute investigators to highlight their accomplishments, to network and explore potential synergies, and to cultivate new collaborations between basic and clinical investigators and clinicians. Over 300 attendees participated in this year's program, which included sessions on cancer immunity, cancer therapeutics, cancer genetics and epigenetics, cancer biomarkers and targets, gene regulation and signaling, population sciences, prevention and detection. This year's keynote speaker, Nicholas Restifo, MD, from the National Cancer Institute (NCI) discussed the development of novel immunotherapies for patients with cancer.

This year's program sessions included:

CANCER IMMUNITY
Moderator: David Roth, MD, PhD

CANCER THERAPEUTICS
Moderator: Owen O'Conner, MD, PhD

CANCER GENETICS AND EPIGENETICS
Moderator: Richard Hayes, DDS, PhD

CANCER BIOMARKERS AND TARGETS
Moderator: Brian Dynlacht, PhD

GENE REGULATION AND SIGNALING
Moderator: Mark Philips, MD

POPULATION SCIENCES, PREVENTION AND DETECTION
Moderator: Max Costa, PhD

KEYNOTE ADDRESS: Developing novel immunotherapies for patients with cancer
NICHOLAS RESTIFO, MD

About NYU Cancer Institute
The mission of the NYU Cancer Institute is to discover the origins of human cancer and to use that knowledge to eradicate the personal and societal burden of cancer in our community, the nation and the world. NYU Cancer Institute is an NCI-designated Cancer Center.

###